UBS lowered the firm’s price target on Oracle (ORCL) to $325 from $380 and keeps a Buy rating on the shares. Oracle’s Q2 results showed 13% revenue growth and 66% cloud infrastructure growth, slightly missing estimates, as did messaging on leverage and financing, though the $523B deal backlog and its 2H/FY27 conversion potential support a Buy rating, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- SMH ETF News: What Moved the Market – 12/11/25
- Oracle’s (ORCL) AI Story Hits a Speed Bump — What’s Next for the Stock?
- Video: Oracle drags on Nasdaq as report reignites AI spending concerns
- Notable open interest changes for December 11th
- MSFT vs. ORCL vs. CRWV: Who Gains Most From OpenAI’s Enterprise Expansion? Jefferies Weighs In